Notifications
Back
Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy.


Small

Impact Factor : 15.153

May 2023


view detail

Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy.


Journal of Controlled Release

Impact Factor : 11.467

Oct 2022


view detail

Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy


Advanced Materials

Impact Factor : 32.086 

Dec 2020


view detail

Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity


Science Advances

Impact Factor : 14.136

Jul 2020


view detail

Intrinsic cancer vaccination


Advanced Drug Delivery Reviews

Impact Factor : 17.873

Nov 2019


view detail

Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery


Journal of Extracellular Vesicles

Impact Factor : 17.337

Dec 2018


view detail

Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer


Advanced Materials

Impact Factor : 32.086

Mar 2018


view detail

Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis


Biomaterials

Impact Factor : 15.304

Mar 2017


view detail

Virus‐mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes


Advanced Materials

Impact Factor : 32.086

Mar 2017


view detail

Functionalized exosome harboring bioactive molecules for cancer therapy


Cancer Letters

Impact Factor : 9.7

Oct 2020


view detail